Facebook Linkedin Twitter
Inside Precision Medicine Shortening of CAR-T Cell Monitoring Period Could Improve Accessibility

Non-hodgkin lymphoma

3d render of CAR T cells attacking and killing blood cancer cells
News & Features

Shortening of CAR-T Cell Monitoring Period Could Improve Accessibility

Helen Albert -
0
Hodgkin lymphoma, light micrograph
News & Features

CAR-T Targeting CD22 Delivers Positive Early Results in Lymphoma 

Malorye Branca -
0
Immunoglobulin G—IgG—antibody molecule
News & Features

Frequent Immunoglobulin Testing Reduces Infections in CLL and NHL Patients

Chris Anderson -
0
Diffuse large B-cell lymphoma
News & Features

Combination Targeted Therapy Regimen Potentially Practice-Changing for DLBCL

Laura Cowen -
0
3d render of CAR T cells attacking and killing blood cancer cells
News & Features

Studies Address Risk for Secondary Cancers Related to CAR T Cell Therapy

Laura Cowen -
0
CAR T cell immunotherapy
News & Features

New Technique Improves T Cell-Based Immunotherapies for Solid Tumors

Alice McCarthy -
0
immune system
News & Features

Cullinan Nets $280M Investment and Targets CD19 in Lupus

Malorye Branca -
0
Diffuse large B-cell lymphoma
News & Features

Protein Group Helps Cancer Cells Hide from Immune System

Chris Anderson -
0
CAR T cell immunotherapy, illustration
News & Features

CD19-Targeted CAR NK Cell Therapy Shows Promise in Treating B-Cell Malignancies

Alisa Kirkin -
0
Hodgkin lymphoma, light micrograph
Molecular Dx

Hodgkin Lymphoma Recurrence Predicted Using ctDNA

Sophia Ktori -
0
123Page 1 of 3

Related Content

Copyright © 2024 Genetic Engineering & Biotechnology News. All Rights Reserved.
Inside Precision Medicine